NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Open An Account
Partner Us
Downloads
Careers
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Cash Flow
Cash Flow
AUROBINDO PHARMA LTD.
NSE :
AUROPHARMA
BSE :
524804
ISIN CODE :
INE406A01037
Industry :
Pharmaceuticals & Drugs
House :
Aurobindo
BSE
925.20
-4.7 (-0.51 %)
PREV CLOSE (
)
929.90
OPEN PRICE (
)
930.15
BID PRICE (QTY)
924.50 (25)
OFFER PRICE (QTY)
924.70 (10)
VOLUME
19122
TODAY'S LOW / HIGH (
)
923.50
937.95
52 WK LOW / HIGH (
)
281.15
996.65
NSE
927.50
-2.5 (-0.27 %)
PREV CLOSE(
)
930.00
OPEN PRICE (
)
935.00
BID PRICE (QTY)
927.10 (10)
OFFER PRICE (QTY)
927.50 (76)
VOLUME
892407
TODAY'S LOW / HIGH(
)
924.40
938.00
52 WK LOW / HIGH (
)
288.85
996.85
Consolidated
Standalone
Rs.in Crores
Rs. in Million
Select year
Mar2020
Mar2019
Mar2018
Mar2017
Mar2016
Particulars
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Profit Before Tax
3743.04
3091.35
3241.18
3060.84
2744.30
Adjustment
1091.17
813.95
535.02
408.92
487.50
Changes In working Capital
276.87
-1484.50
-1123.12
582.52
-1079.41
Cash Flow after changes in Working Capital
5111.08
2420.80
2653.08
4052.28
2152.39
Cash Flow from Operating Activities
4381.28
1650.97
1954.52
3278.58
1419.76
Cash Flow from Investing Activities
-1567.64
-2902.59
-1926.59
-1787.04
-1445.21
Cash Flow from Financing Activities
-1947.18
1919.06
864.15
-1915.26
365.44
Net Cash Inflow / Outflow
866.46
667.44
892.08
-423.72
339.99
Opening Cash & Cash Equivalents
1875.58
1209.94
318.03
743.49
403.81
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balalces frgn subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.78
-1.80
-0.17
-0.14
-0.30
Closing Cash & Cash Equivalent
2746.82
1875.58
1209.94
319.63
743.50